Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ipa-3
2. 42521-82-4
3. Ipa 3
4. 1,1'-dithiodi-2-naphthol
5. 1,1'-disulfanediylbis(naphthalen-2-ol)
6. Ipa3
7. 2-naphthol, 1,1'-dithiodi-
8. 2-naphthalenol, 1,1'-dithiobis-
9. 1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol
10. 3xfg6mq9g2
11. Chembl472940
12. Unii-3xfg6mq9g2
13. 1,1'-dithiodi-2-naphthtol
14. 1,1'-disulfanediyldinaphthalen-2-ol
15. Dihydroxydinaphthyldisulphide
16. Mls006011676
17. F0400-0044
18. Gtpl8940
19. Schembl4907161
20. Chebi:95062
21. Dtxsid70195311
22. Chebi:101355
23. Hms3229j05
24. Hms3263p06
25. Hms3414c17
26. Hms3653g03
27. Hms3678c17
28. Zinc1957909
29. Tox21_501272
30. Bdbm50112354
31. Mfcd00388917
32. S7093
33. Akos001589606
34. Ccg-222576
35. Cs-1432
36. Lp01272
37. Sdccgsbi-0207173.p002
38. 1,1'-disulfanediyldi(naphthalen-2-ol)
39. Ipa-3, >=95% (hplc), Powder
40. Ncgc00186047-01
41. Ncgc00186047-02
42. Ncgc00186047-12
43. Ncgc00261957-01
44. As-82043
45. Hy-15663
46. Smr001456562
47. Sw220299-1
48. D83674
49. 1-[(2-hydroxy-1-naphthyl)disulfanyl]-2-naphthol
50. A918483
51. 1-(2-hydroxynaphthalen-1-yl)disulfanylnaphthalen-2-ol
52. Q27078087
53. 1081767-20-5
| Molecular Weight | 350.5 g/mol |
|---|---|
| Molecular Formula | C20H14O2S2 |
| XLogP3 | 5.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 350.04352203 g/mol |
| Monoisotopic Mass | 350.04352203 g/mol |
| Topological Polar Surface Area | 91.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 380 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A IPA 3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IPA 3, including repackagers and relabelers. The FDA regulates IPA 3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IPA 3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A IPA 3 supplier is an individual or a company that provides IPA 3 active pharmaceutical ingredient (API) or IPA 3 finished formulations upon request. The IPA 3 suppliers may include IPA 3 API manufacturers, exporters, distributors and traders.
IPA 3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IPA 3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right IPA 3 GMP manufacturer or IPA 3 GMP API supplier for your needs.
A IPA 3 CoA (Certificate of Analysis) is a formal document that attests to IPA 3's compliance with IPA 3 specifications and serves as a tool for batch-level quality control.
IPA 3 CoA mostly includes findings from lab analyses of a specific batch. For each IPA 3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IPA 3 may be tested according to a variety of international standards, such as European Pharmacopoeia (IPA 3 EP), IPA 3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IPA 3 USP).
LOOKING FOR A SUPPLIER?
